Japan's Takeda eyeing BRIC countries, with plans for Brazil and India

Japan's leading drugmaker Takeda Pharmaceutical looks set to follow in the footsteps of several other drug majors into the fast-growing markets of the BRIC (Brazil, Russia, India, China) countries, announcing moves into Brazil and India.

Takeda revealed yesterday that it will establish a new commercial subsidiary in Brazil, noting this will represents the 12th new strategic expansion since January this year, including Canada, Spain, Portugal, Ireland, Mexico, Sweden, Norway, Denmark, Belgium, Luxembourg and Turkey.

'Combined with Takeda's additional recent expansions, this opportunity will drive Takeda's ability to maximize the potential of our pipeline in Brazil,' said Alan MacKenzie, executive vice president, International Operations, Takeda Pharmaceuticals International, adding: 'Brazil is an important country in the Latin American region for Takeda to ensure we are providing our products where patients need them.'